Certain probiotic strains produce short-chain fatty acids that can enhance GLP-1 receptor sensitivity, potentially improving medication efficacy
2016;150(5):11471159e1145
However, when combined with insulin or sulfonylureas, the risk of low blood sugar increases, which could potentially trigger headaches in some individuals
GLP-1 medications accelerate weight loss, which means muscle loss is a real and common concern
More serious, though much rarer, risks have been identified, including a potential increased risk of pancreatitis and gallbladder problems
Sie knnen dies zunchst selbst sicherstellen, und zwar durch regelmige krperliche Aktivitt , ausgewogene und regelmige Ernhrung , ausreichend Schlaf , Hydratation